# Fundació d'investigació Sanitària de les Illes Balears: Phase 3 study in Traumatic Brain Injury (TBI) Patients (536 participants)

**Score:** 70/100

| Field | Value |
|---|---|
| Sponsor | Fundació d'investigació Sanitària de les Illes Balears |
| Sponsor type | Non-US government |
| Study | Efficacy of Propranolol in Traumatic Brain Injury Patients Admitted to the ICU: A Prospective, Randomized, Triple-Blind Study |
| NCT ID | NCT07899164 |
| Phase | Phase 3 |
| Status | recruiting |
| Conditions | Traumatic Brain Injury (TBI) Patients |
| Intervention types | drug |
| Target enrollment | 536 |
| Site countries | Spain |
| Posted | 2026-10-27 |
| Planned start | 2026-06-01 |
| Event | Newly registered study |
| Event date | 2026-10-27 |

## Why this score
- Posted in the last two weeks.
- Phase 3: multi-site, larger budget.
- 536 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07899164). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.